Washington Trust Advisors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Washington Trust Advisors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-136	Closed	-$8.46K	–	687
2023 Q4	$8.46K	Buy	+136	New	+$3.38K	﹤0.01%	506

Washington Trust Advisors's RYZB Position: Q1 2024 in Review

Washington Trust Advisors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 136 shares — an estimated $8.46K sold.

Washington Trust Advisors first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $8.46K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Washington Trust Advisors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Washington Trust Advisors sold 136 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $8.46K.
Washington Trust Advisors first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Washington Trust Advisors's RayzeBio, Inc. Common Stock position peaked at $8.46K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Washington Trust Advisors's 13F filing for Q1 2024, filed 7 May 2024.